Fermion
Give me a museum and I'll fill it. (Picasso) Give me a forum ...
I am interested in sharing my current biotech investments and hearing from others about what biotech companies they may be thinking about or invested.
I have dabbled in biotech over the past decade with some (but not great) success. I have probably had the most success with Gilead although it has required a lot of buying and selling on pops and drops instead of the more desirable buy and hold. Ten years ago you could have purchased Gilead and just held it. You would have realized some 500% gain. Recently it has not performed well, even as the PE has dropped below 7. I have 2000 shares right now but will probably trim that back to 1000 if and when some positive news drives the price back near $90. My cost on these shares is around $82. They are generating $3760 per year in dividends which is not bad for buy and hold.
I have a small position in Endocyte (4000 shares), which is a tiny company investigating small molecule delivery systems for destroying cancer tumors. I trimmed back my shares after the CEO left earlier this year although it has not been clear if his reason for leaving had anything at all to do with the company itself. They have more cash on hand than the current market cap and a few drugs in early stage development that are promising but nothing great right now that would knock it out of the park sans a partnership agreement.
I am looking at UTHR (United Therapeutics) now but have just started researching it and may not buy any of that stock at all. They do look interesting...small now but profitable and maybe could be the Gilead, Celgene or Amgen of the future.
I have dabbled in biotech over the past decade with some (but not great) success. I have probably had the most success with Gilead although it has required a lot of buying and selling on pops and drops instead of the more desirable buy and hold. Ten years ago you could have purchased Gilead and just held it. You would have realized some 500% gain. Recently it has not performed well, even as the PE has dropped below 7. I have 2000 shares right now but will probably trim that back to 1000 if and when some positive news drives the price back near $90. My cost on these shares is around $82. They are generating $3760 per year in dividends which is not bad for buy and hold.
I have a small position in Endocyte (4000 shares), which is a tiny company investigating small molecule delivery systems for destroying cancer tumors. I trimmed back my shares after the CEO left earlier this year although it has not been clear if his reason for leaving had anything at all to do with the company itself. They have more cash on hand than the current market cap and a few drugs in early stage development that are promising but nothing great right now that would knock it out of the park sans a partnership agreement.
I am looking at UTHR (United Therapeutics) now but have just started researching it and may not buy any of that stock at all. They do look interesting...small now but profitable and maybe could be the Gilead, Celgene or Amgen of the future.